Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway

Feng,Nan; Luo,Jianmin; Guo,Ximin

doi:10.3892/mmr.2016.4887

Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway

Authors:
- Nan Feng
- Jianmin Luo
- Ximin Guo
View Affiliations

Affiliations: Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuan, Hebei 050000, P.R. China, Academy of Military Medical Sciences of the Chinese PLA, Beijing 100850, P.R. China
Published online on: February 10, 2016 https://doi.org/10.3892/mmr.2016.4887
Pages: 3243-3248

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Silybin is a biologically active component extracted from the seeds of Silybum marianum, which has been shown to have inhibitory effects on prostate, skin, bladder, lung and colon cancer cells, in addition to its efficacy in the treatment of liver diseases, including hepatitis and cirrhosis. The aim of the present study was to investigate whether silybin suppresses the proliferation and induces apoptosis of multiple myeloma (MM) cells and to elucidate its molecular targets. The proliferative and apoptotic rates of the U266 MM cell line were assessed using MTT and flow‑cytometric assays, respectively. Western blot analysis was used to assess the protein levels of phosphoinositide‑3 kinase (PI3K), phosphorylated (p)‑Akt and p‑mammalian target of rapamycin (mTOR) in U266 cells. In addition, PI3K inhibitor LY294002 or activator insulin‑like growth factor 1 were used to investigate the involvement of the PI3K/Akt‑mTOR signaling pathway in the effect of silybin on U266 cells. The results revealed that silybin restrained the proliferation and enhanced the apoptosis of U266 cells. Furthermore, silybin inhibited the protein expression of PI3K, p‑Akt and p‑mTOR in U266 cells. Of note, inhibition of PI3K facilitated silybin‑mediated reduction of mTOR activation, cell proliferation and induction of apoptosis in U266 cells, while activation of PI3K attenuated the effects of silybin. In conclusion, silybin suppressed cell proliferation and promoted apoptosis of U266 cells via PI3K/Akt-mTOR signaling pathways.

View Figures

View References

1	García-Escobar I, Parrilla L, Ortega LM, Castellanos D, Pallarés MA and Cortés-Funés H: Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors. Mol Clin Oncol. 2:923–926. 2014.PubMed/NCBI
2	Yang G, Geng C, Li Y, Liu A and Chen W: Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report. Exp Ther Med. 6:883–886. 2013.PubMed/NCBI
3	Yang LJ, Chen Y, He J, Yi S, Wen L, Zhao S and Cui GH: Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS. Oncol Lett. 3:1159–1165. 2012.PubMed/NCBI
4	Kwon SJ, Lee JH, Moon KD, Jeong IY, Yee ST, Lee MK and Seo KI: Isoegomaketone induces apoptosis in SK-MEL-2 human melanoma cells through mitochondrial apoptotic pathway via activating the PI3K/Akt pathway. Int J Oncol. 45:1969–1976. 2014.PubMed/NCBI
5	Yang Y, Zhou X, Xiao M, Hong Z, Gong Q, Jiang L and Zhou J: Discovery of chrysoeriol, a PI3K-akt-mTOR pathway inhibitor with potent antitumor activity against human multiple myeloma cells in vitro. J Huazhong Univ Sci Technolog Med Sci. 30:734–740. 2010. View Article : Google Scholar : PubMed/NCBI
6	Agarwal C, Wadhwa R, Deep G, Biedermann D, Gažák R, Křen V and Agarwal R: Anti-cancer efficacy of silybin derivatives-a structure-activity relationship. PLoS One. 8:e600742013. View Article : Google Scholar
7	Tan C, Xu X, Shang Y, Fu X, Xia G and Yang H: A novel approach for the efficient extraction of silybin from milk thistle fruits. Pharmacogn Mag. 10:536–540. 2014. View Article : Google Scholar : PubMed/NCBI
8	Gándara L, Sandes E, Di Venosa G, Prack McCormick B, Rodriguez L, Mamone L, Batlle A, Eiján AM and Casas A: The natural flavonoid silybin improves the response to photodynamic therapy of bladder cancer cells. J Photochem Photobiol B. 133:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
9	Mahmoodi N, Motamed N and Paylakhi SH: The comparison of the effects of silybin and silybin-phosphatidylcholine on viability and ESR expression in human breast cancer T47D cell line. Cell. J16:299–308. 2014.
10	Zhang S, Yang Y, Liang Z, Duan W, Yang J, Yan J, Wang N, Feng W, Ding M, Nie Y and Jin Z: Silybin-mediated inhibition of notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLoS One. 8:e836992013. View Article : Google Scholar
11	Rui M, Huang Z, Liu Y, Wang Z, Liu R, Fu J and Huang H: Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression. Mol Med Rep. 10:2137–2143. 2014.PubMed/NCBI
12	Lin M, Zhu J, Shen H and Huang J: Gastrointestinal bleeding as an initial manifestation in asymptomatic multiple myeloma: A case report and review of the literature. Oncol Lett. 5:218–220. 2013.
13	Kabir AL, Rahman MJ, Begum M, Dipta TF, Baqui MN, Aziz A, Rahman F, Debnath RC and Habib MA: Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma. Mymensingh Med J. 21:114–119. 2012.PubMed/NCBI
14	Siegel AB, Narayan R, Rodriguez R, Goyal A, Jacobson JS, Kelly K, Ladas E, Lunghofer PJ, Hansen RJ, Gustafson DL, et al: A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma. Integr Cancer Ther. 13:46–53. 2014. View Article : Google Scholar
15	Wang L, Wu J, Lu J, Ma R, Sun D and Tang J: Regulation of the cell cycle and PI3K/akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines. Mol Med Rep. 11:931–939. 2015.
16	Wang W, Ren F, Wu Q, Jiang D, Li H and Shi H: MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. Oncol Rep. 32:2127–2133. 2014.PubMed/NCBI
17	García-Maceira P and Mateo J: Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: Implications for anticancer therapy. Oncogene. 28:313–324. 2009. View Article : Google Scholar
18	Zhang Y, Hai J, Cao M, Zhang Y, Pei S, Wang J and Zhang Q: Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/akt pathway. Int Immunopharmacol. 17:714–720. 2013. View Article : Google Scholar : PubMed/NCBI
19	Gong G, Hu L, Liu Y, Bai S, Dai X, Yin L, Sun Y, Wang X and Hou L: Upregulation of HIF-1α protein induces mitochondrial autophagy in primary cortical cell cultures through the inhibition of the mTOR pathway. Int J Mol Med. 34:1133–1140. 2014.PubMed/NCBI
20	Chang Z, Shi G, Jin J, Guo H, Guo X, Luo F, Song Y and Jia X: Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Int J Mol Med. 31:1449–1456. 2013.PubMed/NCBI
21	Raina K, Agarwal C, Wadhwa R, Serkova NJ and Agarwal R: Energy deprivation by silibinin in colorectal cancer cells: A double-edged sword targeting both apoptotic and autophagic machineries. Autophagy. 9:697–713. 2013. View Article : Google Scholar : PubMed/NCBI
22	Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW and Cheng YW: Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/akt/mTOR pathway. Br J Pharmacol. 168:920–931. 2013. View Article : Google Scholar :
23	Han S, Zhang G, Li M, Chen D, Wang Y, Ye W and Ji Z: L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway. Oncol Rep. 31:2245–2251. 2014.PubMed/NCBI
24	Liu X, Wang L, Chen J, Ling Q, Wang H, Li S, Li L, Yang S, Xia M and Jing L: Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway. Mol Med Rep. 11:1516–1522. 2015.
25	Wang C, Wang Z, Zhang X, Zhang X, Dong L, Xing Y, Li Y, Liu Z, Chen L, Qiao H, et al: Protection by silibinin against experimental ischemic stroke: Up-regulated pAkt, pmTOR, HIF-1α and Bcl-2, down-regulated Bax, NF-κB expression. Neurosci Lett. 529:45–50. 2012. View Article : Google Scholar : PubMed/NCBI